Thermo Fisher Scientific is trading 3.07% up now at $632.36, reflecting continued healthcare-sector rotation and investor confidence following its second-quarter beat and raised 2026 outlook.
- Shares extended a 4.16% gain on August 19.
- No fresh company-specific announcement or analyst action was identified for August 20.
- 2026 guidance includes $47.4 billion-$48.1 billion in revenue and $24.93-$25.33 in adjusted EPS.